AU7173698A - Lipophilic and/or lytic peptides for specific delivery of nucleic acids to ce lls - Google Patents

Lipophilic and/or lytic peptides for specific delivery of nucleic acids to ce lls

Info

Publication number
AU7173698A
AU7173698A AU71736/98A AU7173698A AU7173698A AU 7173698 A AU7173698 A AU 7173698A AU 71736/98 A AU71736/98 A AU 71736/98A AU 7173698 A AU7173698 A AU 7173698A AU 7173698 A AU7173698 A AU 7173698A
Authority
AU
Australia
Prior art keywords
lls
lipophilic
nucleic acids
specific delivery
lytic peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71736/98A
Inventor
Mark Logan
Alain Rolland
Louis C Smith
James T. Sparrow
Manpreet S. Wadwha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Genemedicine Inc
Original Assignee
Baylor College of Medicine
Genemedicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine, Genemedicine Inc filed Critical Baylor College of Medicine
Publication of AU7173698A publication Critical patent/AU7173698A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
AU71736/98A 1997-05-02 1998-04-30 Lipophilic and/or lytic peptides for specific delivery of nucleic acids to ce lls Abandoned AU7173698A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4529597P 1997-05-02 1997-05-02
US60045295 1997-05-02
PCT/US1998/008849 WO1998050078A1 (en) 1997-05-02 1998-04-30 Lipophilic and/or lytic peptides for specific delivery of nucleic acids to cells

Publications (1)

Publication Number Publication Date
AU7173698A true AU7173698A (en) 1998-11-27

Family

ID=21937081

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71736/98A Abandoned AU7173698A (en) 1997-05-02 1998-04-30 Lipophilic and/or lytic peptides for specific delivery of nucleic acids to ce lls

Country Status (2)

Country Link
AU (1) AU7173698A (en)
WO (1) WO1998050078A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1052287A3 (en) * 1999-05-10 2003-07-09 Transgene S.A. Complex for transferring an anionic substance of interest into a cell
EP1052288A1 (en) * 1999-05-10 2000-11-15 Transgene S.A. Complex for transferring an anionic substance of interest into a cell
EP1170373A1 (en) * 2000-07-03 2002-01-09 Retina France Peptide-mediated ocular cell transfection
US7446099B2 (en) 2004-02-27 2008-11-04 Nitto Denko Corporation Compositions and methods for biodegradable polymer-peptide mediated transfection
FR2966827B1 (en) * 2010-10-27 2014-08-22 Kimonella Ventures Ltd PEPTIDE COMPOUND USEFUL FOR INHIBITING AMYLOID PLATE FORMATION
DK2691443T3 (en) 2011-03-28 2021-05-03 Massachusetts Inst Technology CONJUGIATED LIPOMERS AND USES OF THESE
EP4074694A1 (en) * 2011-10-27 2022-10-19 Massachusetts Institute Of Technology Amino acid-, peptide- an polypeptide-lipids, isomers, compositions, an uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU705035B2 (en) * 1995-06-07 1999-05-13 Baylor College Of Medicine Nucleic acid transporters for delivery of nucleic acids into a cell
US6344436B1 (en) * 1996-01-08 2002-02-05 Baylor College Of Medicine Lipophilic peptides for macromolecule delivery
EP0784984B1 (en) * 1996-01-17 2003-07-02 F. Hoffmann-La Roche Ag Transfection competent molecules
US5948681A (en) * 1996-08-14 1999-09-07 Children's Hospital Of Philadelphia Non-viral vehicles for use in gene transfer

Also Published As

Publication number Publication date
WO1998050078A1 (en) 1998-11-12

Similar Documents

Publication Publication Date Title
PL336889A1 (en) Preparations of activated protein c
EP0948513A4 (en) Delivery construct for antisense nucleic acids and methods of use
HUP0003761A2 (en) Substituted alkanohydroxamic acids and pharmaceutical compositions containing them
HK1003503A1 (en) Aerosol formulations of peptides and proteins
HUP9801207A3 (en) Therapeutic compositions for transfecting nucleic acids and use thereof
AU4231897A (en) Compositions and methods for delivery of nucleic acids to hepatocytes
HUP0001272A3 (en) Direct expression of peptides into culture media
HU9502702D0 (en) Dna constructs that contain influenza-virus genes and pharmaceutical preparations containing them
HUP9701554D0 (en) Pharmaceutical composition containing plazma proteins
AU8264898A (en) Human jagged polypeptide, encoding nucleic acids and methods of use
AUPN741696A0 (en) Delivery of nucleic acids ii
AU1222901A (en) Polypeptides having phospholipase b activity and nucleic acids encoding same
EP1007706A4 (en) Rna binding protein and binding site useful for expression of recombinant molecules
AU2773695A (en) Compositions for and methods of enhancing delivery of nucleic acids to cells
AU6667998A (en) Nucleic acids encoding caspase-8h and caspase-8i
PL337942A1 (en) Isolated genes of dendricall cell membranic proteins
IL113484A0 (en) Viral proteins pharmaceutical compositions containing them their preparation and use
AU7758598A (en) Stable pharmaceutical administration forms of peptides, proteins and nucleic acids
AU1870597A (en) Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
AU7173698A (en) Lipophilic and/or lytic peptides for specific delivery of nucleic acids to ce lls
NO991839D0 (en) Methods and Preparations for Delivery and Expression of Interferon <alfa> Nucleic Acids
IL123849A0 (en) Pharmaceutical composition useful for nucleic acid transfection and use thereof
AU5602100A (en) Recombinant prion-like genes and proteins and materials and methods comprising same
GB9515356D0 (en) Improvements in or relating to delivery of nucleic acid
AU4904097A (en) Gene delivery and expression in areas inaccessible to direct protein delivery

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase